RT Journal Article
SR Electronic
A1 Kuznar, Wayne
T1 Dual PPAR Agonist Fails to Improve CV Outcomes after ACS (AleCardio)
JF MD Conference Express
YR 2014
FD SAGE Publications
VO 14
IS 4
SP 18
OP 19
DO 10.1177/155989771404008
UL http://mdc.sagepub.com/content/14/4/18.abstract
AB A dual agonist of peroxisome proliferator-activated receptors (PPARs) did not reduce adverse cardiovascular outcomes in patients with type 2 diabetes mellitus. Findings from the Phase 3, multinational, AleCardio study [Lincoff AM et al. JAMA 2014] are discussed in this article.